CASE REPORT OF AUTOIMMUNE HEPATITIS AND CONCOMITANT PRIMARY BILIARY CHOLANGITIS
DOI:
https://doi.org/10.56238/isevmjv4n4-017Keywords:
Autoimmune Hepatitis, Primary Biliary Colangitis, AutoantibodiesAbstract
Autoimmune hepatitis with concomitant primary biliary cholangitis has rarely been reported. In this case, we describe a 57-year-old woman who had criteria for this diagnosis based on a liver biopsy that showed a mixed infiltrate of lymphocytes associated with interface hepatitis, rosettes, emperipolesis, plasma cells, and over 50% of the portal ducts did not have a central biliary duct. The treatment provided was Azathioprine, prednisone, and omeprazole, which led to a remarkable complete normalization of her liver enzymes after four weeks. This successful treatment outcome underscores the importance of early identification and treatment for improving long-term outcomes.
References
Domerecka, W., Homa-Mlak, I., Mlak, R., Michalak, A., Wilińska, A., Kowalska-Kępczyńska, A., ... & Dreher, P. (2022). Indicator of inflammation and NETosis—Low-density granulocytes as a biomarker of autoimmune hepatitis. Journal of Clinical Medicine, 11(8), 2170. https://doi.org/10.3390/jcm11082170
Fan, J. H., Liu, G. F., Lv, X. D., Zeng, R. Z., Zhan, L. L., & Lv, X. P. (2021). Pathogenesis of autoimmune hepatitis. World Journal of Hepatology, 13(8), 879–886. https://doi.org/10.4254/wjh.v13.i8.879
Hahn, J. W., Yang, H. R., Moon, J. S., Chang, J. Y., Lee, K., Kim, G. A., ... & Ko, J. S. (2023). Global incidence and prevalence of autoimmune hepatitis, 1970–2022: A systematic review and meta-analysis. EClinicalMedicine, 65, 102280. https://doi.org/10.1016/j.eclinm.2023.102280
Jo, H. I., Kim, M., Yoo, J. J., Kim, S. G., Kim, Y. S., & Chin, S. (2022). Acute hepatitis A-induced autoimmune hepatitis: A case report and literature review. Medicina, 58(7), 903. https://doi.org/10.3390/medicina58070903
Llovet, L. P., Gratacós-Ginés, J., Ortiz, O., Rodriguez-Tajes, S., Lens, S., Reverter, E., ... & Londoño, M. C. (2020). Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodies. Liver International, 40(3), 558–564. https://doi.org/10.1111/liv.14329
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., ... & Mieli-Vergani, G. (2020). Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology, 72(2), 671–722. https://doi.org/10.1002/hep.31065
Mieli-Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., ... & Chapman, R. W. (2018). Autoimmune hepatitis. Nature Reviews Disease Primers, 4, 18017. https://doi.org/10.1038/nrdp.2018.17
Schultheiß, C., Steinmann, S., Lohse, A. W., & Binder, M. (2022). B cells in autoimmune hepatitis: Bystanders or central players? Seminars in Immunopathology, 44(4), 411–427. https://doi.org/10.1007/s00281-022-00927-8
Sherigar, J. M., Yavgeniy, A., Guss, D., Ngo, N., & Mohanty, S. (2017). Seronegative autoimmune hepatitis: A clinically challenging difficult diagnosis. Case Reports in Medicine, 2017, 3513608. https://doi.org/10.1155/2017/3513608
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2018). The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview. Journal of Autoimmunity, 95, 144–158. https://doi.org/10.1016/j.jaut.2018.10.004
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Luis Alvarez-Ankass, Richard Salinas-Benavides, Julio Fuenzalida-Valdivia, Karlo Terreros-Abril, Edith Ramos-Ocola
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
